| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.0076 | 1 |